Table 3.
Association between creatinine-based estimated glomerular filtration rate (eGFR) and mitral annular calcifications (MAC), aortic annular calcifications (AAC) and aortic valve sclerosis (AVS)
eGFR | ||||
---|---|---|---|---|
>60 mL/min/1.73 m2 | 45–60 mL/min/1.73 m2 | <45 mL/min/1.73 m2 | P for trend | |
N = 2777 | N = 710 | N = 214 | ||
MAC | ||||
Model 1a | Reference | 0.97 (0.82–1.15) | 1.65 (1.24–2.20) | 0.019 |
Model 2b | Reference | 0.94 (0.79–1.11) | 1.54 (1.16–2.06) | 0.082 |
AAC | ||||
Model 1a | Reference | 0.98 (0.82–1.17) | 1.36 (1.02–1.82) | 0.169 |
Model 2b | Reference | 0.95 (0.80–1.14) | 1.30 (0.97–1.74) | 0.340 |
AVS | ||||
Model 1a | Reference | 1.01 (0.85–1.20) | 1.22 (0.91–1.62) | 0.299 |
Model 2c | Reference | 0.98 (0.82–1.16) | 1.15 (0.86–1.53) | 0.599 |
MAC, AAC and AVS were defined as present or absent, i.e. summing mild, moderate or severe versus none. Data presented as OR (95% confidence intervals).
aAdjusted for age, gender and race.
bAdjusted for age, gender, race, prevalent cardiovascular disease and HDL-cholesterol.
cAdjusted for age, gender, race, prevalent cardiovascular disease, hypertension, HDL-cholesterol and waist-hip-ratio.